In the third episode of BioDech,  a global life sciences broadcast series, Jolie Siegel, Chief Legal Officer of C4 Therapeutics, Inc., and Marco Taglietti, M.D., Independent Board Director of Aquestive Therapeutics, join Dechert's John Alessi and Stephen Leitzell to discuss corporate governance considerations leading up to an IPO, including board composition, financial controls and overall risk management, and forward-looking concerns for newly public companies.

Learn more.